VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Bio-Rad Laboratories, Inc. vs Linde plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Bio-Rad Laboratories, Inc.
BIO · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Bio-Rad Laboratories, Inc.'s moat claims, evidence, and risks.
View BIO analysisLinde plc
LIN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Linde plc leads (72 / 100 vs 61 / 100 for Bio-Rad Laboratories, Inc.).
- Segment focus: Bio-Rad Laboratories, Inc. has 2 segments (59.9% in Clinical Diagnostics); Linde plc has 4 segments (43.8% in Americas).
- Moat breadth: Bio-Rad Laboratories, Inc. has 6 moat types across 3 domains; Linde plc has 5 across 3.
Primary market context
Bio-Rad Laboratories, Inc.
Clinical Diagnostics
In vitro diagnostics test systems, reagents/test kits, informatics, and clinical laboratory quality controls
Global
Hospital laboratories; diagnostic reference laboratories; transfusion laboratories; physician office laboratories
IVD OEM / installed-base consumables supplier (systems + kits + controls)
59.9%
Linde plc
Americas
Industrial gases (Americas)
Americas
B2B + healthcare
Producer, distributor, on-site plant owner/operator
43.8%
Side-by-side metrics
Moat coverage
Shared moat types
Bio-Rad Laboratories, Inc. strengths
Linde plc strengths
Segment mix
Bio-Rad Laboratories, Inc. segments
Full profile >Life Science
Competitive
Clinical Diagnostics
Oligopoly
Linde plc segments
Full profile >Americas
Oligopoly
EMEA
Oligopoly
APAC
Oligopoly
Engineering
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.